Advertisement

Topics

Immunotherapy, gene editing advances extend to Type 1 Diabetes

19:00 EST 12 Dec 2017 | AAAS

(Seattle Children's) Advances in engineering T cells to treat cancer are paving the way for new immunotherapies targeted at autoimmune diseases, including type 1 diabetes. Now, researchers are also investigating therapies that reprogram T cells to 'turn down' an immune response, which may hold promise for curing type 1 diabetes, as well as a number of diseases where overactive T cells attack a person's healthy cells and organs.

Original Article: Immunotherapy, gene editing advances extend to Type 1 Diabetes

NEXT ARTICLE

More From BioPortfolio on "Immunotherapy, gene editing advances extend to Type 1 Diabetes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...